The Single-Compound Paradigm and Its Shortcomings
Environmental health regulation has historically evaluated chemical risks one compound at a time. Maximum contaminant levels, health advisories, and acceptable daily intakes are derived from studies of individual compounds, and compliance determinations ask whether any single compound exceeds its individual threshold. This paradigm is computationally tractable and scientifically defensible for isolated exposures, but it fundamentally misrepresents the real-world experience of human populations living with PFAS-contaminated water, where multiple compounds are invariably present simultaneously.
Data from PFAS monitoring surveys in the United States, Europe, and Australia consistently show that when any one PFAS compound is detected in a drinking water source, multiple other PFAS compounds are almost always co-detected. The EPA’s Unregulated Contaminant Monitoring Rule (UCMR5) dataset, which sampled thousands of public water systems for 29 PFAS compounds, found that systems with detections typically had three to six PFAS compounds above minimum reporting levels. In communities near industrial sources or military installations using aqueous film-forming foam (AFFF), a dozen or more PFAS compounds may co-occur at measurable concentrations.
The Additivity Evidence Base
The EPA’s Hazard Index approach for PFAS mixtures is grounded in the additivity assumption: compounds sharing a common mechanism of toxicity produce effects that sum arithmetically across the mixture. For thyroid hormone disruption — the endpoint driving much of the PFAS health concern for children and pregnant women — multiple lines of evidence support additivity as a conservative and scientifically appropriate default. In vitro studies have shown that PFOA, PFOS, PFHxS, PFNA, and PFBS each individually interact with thyroid hormone transport and receptor systems, and that their combined effects on T4 displacement and thyroid receptor binding are approximately additive across relevant concentration ranges.
Animal studies using PFAS mixtures at concentrations where individual compounds produce no statistically significant thyroid effects have found measurable thyroid hormone perturbations in the mixture groups. A 2022 study using a six-compound PFAS mixture at doses scaled to U.S. population geometric mean serum concentrations found significant reductions in total T4 and T3 in gestational exposure models, despite no individual compound being present at its single-compound NOAEL. These results directly validate the concern that single-compound compliance does not guarantee safety when multiple sub-threshold PFAS co-occur.
Immune Function and the Mixture Evidence
Thyroid disruption is not the only endpoint where mixture effects have been documented. The epidemiological literature on PFAS and vaccine immune response has increasingly moved toward mixture analyses. Studies examining the relationship between childhood PFAS exposure and antibody titers following routine vaccination have found that mixture-based analyses (using Bayesian Kernel Machine Regression or weighted quantile sum regression) identify associations at lower exposure levels than single-compound analyses. The immune suppression signal, initially attributed primarily to PFOA and PFOS, has been extended to include PFNA, PFHxS, and PFDA as mixture contributors in recent 2023–2025 analyses.
This has regulatory implications for childhood vaccination programs: children in high-PFAS-exposure communities may have blunted vaccine responses regardless of whether any single PFAS compound exceeds its individual MCL. The public health consequence — reduced herd immunity and potentially higher susceptibility to vaccine-preventable diseases — extends beyond the individual child to population-level infectious disease dynamics, representing a societal cost that single-compound risk frameworks are not designed to capture.
The Hazard Index Approach: Strengths and Limitations
The EPA’s Hazard Index (HI) for the PFAS quintet (PFOA + PFOS + PFNA + PFHxS + PFBS + HFPO-DA summed as fractions of their respective MCLs) represents a meaningful advance over pure single-compound regulation. By requiring that the sum of fractional concentrations not exceed 1.0, it effectively ensures that even low levels of multiple compounds do not cumulatively exceed what would be allowed for a single compound in isolation. This approach has scientific precedent in EPA methodology for chlorinated solvents and other chemical classes.
However, the Hazard Index has known limitations. First, it covers only six PFAS compounds, while real-world mixtures typically contain many more. Second, it applies only to compounds sharing specific regulatory thresholds, excluding TFA, precursor PFAS, and the hundreds of other PFAS detected in water but not yet assigned MCLs. Third, the additivity assumption, while appropriate as a regulatory default, may underestimate risk for mixtures containing compounds with synergistic interactions — an area where research is still maturing. Communities and utilities should treat HI compliance as a floor, not a ceiling, for PFAS risk management decisions.